Diabetes drugs on the market or in the pipeline.

1. Diabetic Drugs on Market or In Pipeline at July 6, 2011
offshore approval
under review
on market
extension
Phase III
Phase II
Phase I
Company drug or product indication/substance
Degludec t1 and t2 diabetes x x x
DegludecPlus t1 and t2 diabetes x x x
Semaglutide t2 diabetes x x
NN1953 t1 and t2 diabetes x
NN9068 t2 diabetes x
NN9924 t2 diabetes x
Novo Nordisk NovoLog Mix 70/30 insulin x
NovoLog insulin x
Levamir insulin x
insulin pens diabetes x
Prandin t2 diabetes x
Glucagen hypo kit diabetes x
Victoza t2 diabetes x
Januvia t2 diabetes x
Janumet t2 diabetes x
MK3102 diabetes mellitus x
MK0431C diabetes x
Merck MK0431A (sitagliptin/
Extended-release
metformin) diabetes x
MK0431D
sitagliptin/simvastatin diabetes x
Kombiglyze™ XR/
Onglyza™/metformin IR
FDC# diabetes x
Dapagliflozin/metformin
FDC# diabetes x
Astra Zeneca Dapagliflozin diabetes x
AZD1656 diabetes x x
AZD8329 diabetes/obesity x x
AZD7687 diabetes/obesity x x
AZD5658 diabetes/obesity x x
saxagliptin diabetes x
Lyrica diabetic neuropathy x
Pfizer Lyrica neuropathic pain x
Macugen diabetic macular edema x
albiglutide t2 diabetes x
otelixizumab t1 diabetes x x
GlaxoSmithKline albiglutide t2 diabetes x
1614235 t2 diabetes x
2245840 t2 diabetes x
diabetic peripheral
Cymbalta neuropathic pain x
Humalog diabetes x
Humulin diabetes x
Byetta (w/Amylin) t2 diabetes x
Eli Lilly Actos t2 diabetes x
BI10773 diabetes x
GLP-1 Fc t2 diabetes x
Arxxant diabetic retinopathy x
Linagliptin diabetes x
Avapro diabetic nephropathy x
Bristol Myers ONGLYZA diabetes x
Squibb KOMBIGLYZE diabetes x
Dapagliflozin diabetes x
chronic kidney disease
Abbott
Bardoxolone methyl and t2 diabetes x
Byetta (w/Eli Lilly) t2 diabetes x
Amylin
Symlin t2 diabetes x
Pharmaceuticals
Bydureon t2 diabetes x